Since memory loss is characteristic of Alzheimer disease (AD), and since K+ channels change during acquisition of memory in both molluscs and mammals, we investigated K+ channel function as a possible site of AD pathology and, therefore, as a possible diagnostic index as well. A 113-pS tetraethylammonium (TEA)-sensitive K+ channel was consistently absent from AD fibroblasts, while it was often present in young and aged control fibroblasts. A second (166-pS) K+ (28) . Membrane potential was measured both prior to obtaining outside-out patches and by using the "perforated-patch" technique (28, 37) . Before recording, culture medium was replaced with the following solution (mM): NaCl 150, KCI 5, CaCl2 2, MgCl2 1, Hepes (NaOH) 10, pH = 7.4. Pipettes were made from Blue Tip capillary tubes (i.d. 1.1-1.2 mm) by using a BB-CH Mecanex puller and then filled with a high-K+ solution (mM): KCI 140, CaCl2 2, MgCl2 1, Hepes (NaOH) 10, pH = 7.4. Pipette resistances were -6 MQl. Records were obtained by using an Axopatch-1C amplifier (dc to 10 kHz), stored on tape (Toshiba PCM video recorder), and later transferred to a personal computer using an Axolab interface. Only recordings lasting for at least 3 min were considered for final analysis. The pClamp suite of programs was used for singlechannel data acquisition and analysis. Amplifier, interface, and software were obtained from Axon Instruments (Foster
Clinical diagnosis of Alzheimer disease (AD) includes satisfaction of several criteria such as prolonged loss of memory, impaired social and/or work functions, gradual onset, and progressive decline. A clinical diagnosis of AD also requires exclusion of a host of other neurological, psychiatric, and medical disorders (1) . Even in the absence of these other disorders, however, AD patients may not satisfy enough clinical criteria to be clearly distinguished from other individuals who are simply showing the signs of old age. Thus, all-too-common errors in antemortem diagnosis of AD (2) might be significantly reduced by a laboratory test that does distinguish AD from old age and from other neurological and psychiatric disorders.
Designs for such a laboratory test are suggested by what is known at present about AD etiology and pathophysiology. AD has been directly and indirectly linked to a genetic origin (3) (4) (5) . Proposed causes and/or predisposing factors have ranged from defects in f-amyloid protein metabolism (6) (7) (8) (9) (10) (11) (12) and environmental factors (13, 14) to abnormal Ca2+ homeostasis and/or Ca2+-activated kinases (15) (16) (17) (18) (19) (20) (21) (22) . Since memory loss is characteristic of AD (14) and since K+ channels change during acquisition of memory in both molluscs and mammals (23) (24) (25) (26) (27) , we investigated K+ channel function as a possible site of AD pathology and, therefore, as a possible diagnostic index as well. If AD is a systemic process involving multiple organ systems, derangement of K+ channel function might occur within membranes of diverse cell types and not only in neurons during the clinical onset of the disease. Indeed, using patch-clamp (28, 29) and calciumimaging techniques (30, 31) , we report here evidence that a 113-pS K+ channel is functionally absent in fibroblasts of AD The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
patients but not in fibroblasts of age-matched control (AC) or young control (YC) individuals.
METHODS
Cell Lines. Cultured skin fibroblasts from the Coriell Cell Repositories (Camden, NJ) were grown under highly standardized conditions (32) . Six YC (three males, three females; 21.5 ± 2.8 years, mean ± SD), five AC (one male, four females; 65.2 ± 6.0 years), and seven AD (three males, four females; 60.5 ± 6.8 years) cell lines were used for patchclamp experiments. Five AD lines were from familial patients. Some of the lines (two AC and four AD) were from the Canadian kindred (33) (Table 3) . Additional description of these cell lines can be found elsewhere (34, 35 (28) . Membrane potential was measured both prior to obtaining outside-out patches and by using the "perforated-patch" technique (28, 37) . Before recording, culture medium was replaced with the following solution (mM): NaCl 150, KCI Fig. 3 ). Every AC cell line (n = 10) and all but one YC cell line (n = 6) had cells with criterion responses to 100 mM TEA, while none of the 13 AD cell lines examined had cells with criterion responses ( There were, in addition, patients from six other families with members whose fibroblast K+ channels were dysfunctional. All of the five AD lines from one family showed K+ channel dysfunction, while both of the two AC lines from the same family showed normal K+ channel function. The TEAinduced [Ca2+]i elevation was also measured in a third control group, consisting of fibroblasts from neurological (Parkinson disease, Huntington disease, and Wemicke-Korsakoff syndrome) and psychiatric (schizophrenia) patients. Criterion (normal) TEA responses were observed in fibroblasts from the Parkinson patient, from the two schizophrenia patients, from all four Wemicke-Korsakoff patients, and from five of seven Huntington patients (Table 4 ). The TEA responses from this group are virtually identical to the responses found in YC and AC fibroblasts, while they are significantly different from the negative TEA response observed in AD fibroblasts (P < 0.0001, Fisher's exact test).
DISCUSSION
It should be pointed out that the patch-clamp method, because of its low success rate and because it samples only an extremely small fraction of the total cell membrane, has a much greater likelihood of missing K+ channels than does the method of imaging TEA-elicited Ca2+ signals. This was why two independent measures of K+ channel function were used here. Nevertheless, the patch-clamp and [Ca2+], measurements were in good agreement insofar as they both indicated K+ channel dysfunction in the AD fibroblasts. The 113-pS channel that was found by the patch-clamp to be absent from AD fibroblasts could, of course, be "present" but not functional in AD. Such dysfunction could involve structural changes in the channel itself and/or alteration in processes involved in channel activity regulation. It will be important to Proc. Natl. Acad Sci. USA 90 (1993) Proc. Natl. Acad. Sci. USA 90 (1993) 8213 examine possible relationships of the changes reported here to derangement of 13-amyloid protein metabolism (6-12) as well as previously implicated molecular mechanisms of associative memory (24) . A systematic between-group variation of ,3amyloid protein among fibroblasts has, thus far, never been reported, to our knowledge. Future research must concern such questions as well as the possible relevance of the present fibroblast findings for neurons and the functional integrity of the brain.
Since the TEA-elicited Ca2+ signal essentially never occurred in the fibroblasts of patients with AD, with or without a family history of AD, and occurred in some fibroblasts of every AC individual, it clearly distinguishes between individuals suffering from AD and those showing the signs of normal aging. At a minimum, therefore, the TEA-induced Ca2+ signal might provide the basis for an AD screening test for older populations, in much the same way that the tuberculin skin test (using purified protein derivative, PPD) usefully screens for tuberculosis (39, 40) or an ELISA test screens for AIDS (41, 42) . At a maximum, the TEA-elicited Ca2+ signal might also provide a new means of excluding other neurologic, psychiatric, and medical disorders which now can be assessed with a variety of clinical and laboratory methods. We have shown here that, at least for some neurological and psychiatric disorders, the TEA response is normal and, therefore, the method distinguishes AD not only from normal aging but also potentially from Parkinson disease, Huntington disease, and Wernicke-Korsakoff syndrome. It should be emphasized, however, that analysis of freshly obtained cells from a variety of neurological patients as well as an expanded sample of AD patients will be necessary to more definitively establish the clinical testing value of this method. It will also be important to establish how early in the course of AD K+ channel dysfunction appears and to determine whether it appears even prior to the onset of the disease itself.
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